XML 14 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Sep. 30, 2018 $ 9,657 $ 6,052,161 $ (10,457,710) $ (4,395,892)
Balance, shares at Sep. 30, 2018 9,656,505      
Issuance of common stock under securities purchase agreement $ 330 601,319 601,649
Issuance of common stock under securities purchase agreement, shares 330,000      
Issuance of warrants under private placements 223,351 223,351
Issuance costs related to private placements (149,316) (149,316)
Issuance of common stock for consulting services $ 50 114,950 115,000
Issuance of common stock for consulting services, shares 50,000      
Net loss (1,352,824) (1,352,824)
Balance at Dec. 31, 2018 $ 10,037 6,842,465 (11,810,534) (4,958,032)
Balance, shares at Dec. 31, 2018 10,036,505      
Balance at Sep. 30, 2018 $ 9,657 6,052,161 (10,457,710) (4,395,892)
Balance, shares at Sep. 30, 2018 9,656,505      
Balance at Jun. 30, 2019 $ 13,418 15,598,556 (15,885,371) (273,397)
Balance, shares at Jun. 30, 2019 13,417,765      
Balance at Dec. 31, 2018 $ 10,037 6,842,465 (11,810,534) (4,958,032)
Balance, shares at Dec. 31, 2018 10,036,505      
Issuance of common stock under securities purchase agreement $ 1,744 3,164,640 3,166,384
Issuance of common stock under securities purchase agreement, shares 1,743,979      
Issuance of warrants under private placements 1,193,564 1,193,564
Issuance costs related to private placements (698,777) (698,777)
Issuance of common stock upon conversion of convertible promissory notes $ 839 1,920,881 1,921,720
Issuance of common stock upon conversion of convertible promissory notes, shares 839,179      
Issuance of warrants and reclassification of warrant liability upon conversion of convertible promissory notes 1,565,402 1,565,402
Issuance of warrants and reclassification of warrant liability upon conversion of convertible promissory notes, shares      
Share-based compensation - employee 30,085 30,085
Share-based compensation - non-employee 16,569 16,569
Exercise of stock options $ 94 3,179 3,273
Exercise of stock options, shares 93,555      
Exercise of warrants $ 231 416,102 416,333
Exercise of warrants, shares 231,296      
Net loss (2,211,890) (2,211,890)
Balance at Mar. 31, 2019 $ 12,945 14,454,110 (14,022,424) 444,631
Balance, shares at Mar. 31, 2019 12,944,514      
Issuance of common stock under securities purchase agreement $ 388 708,162 708,550
Issuance of common stock under securities purchase agreement, shares 388,200      
Issuance of warrants under private placements 261,950 261,950
Issuance costs related to private placements (99,342) (99,342)
Granting of options previously recorded as a liability 38,696 38,696
Share-based compensation - employee 169,658 169,658
Share-based compensation - non-employee 62,430 62,430
Exercise of stock options $ 85 2,892 2,977
Exercise of stock options, shares 85,051      
Net loss (1,862,947) (1,862,947)
Balance at Jun. 30, 2019 $ 13,418 15,598,556 (15,885,371) (273,397)
Balance, shares at Jun. 30, 2019 13,417,765      
Balance at Sep. 30, 2019 $ 13,494 15,987,799 (17,238,871) (1,237,578)
Balance, shares at Sep. 30, 2019 13,493,705      
Issuance of common stock under securities purchase agreement $ 142 254,858 255,000
Issuance of common stock under securities purchase agreement, shares 141,666      
Issuance of broker warrants in connection with convertible notes offering 419,635 419,635
Stock-based compensation 463,084 463,084
Issuance of common stock for consulting services $ 90 124,503 124,593
Issuance of common stock for consulting services, shares 90,000      
Issuance of common stock upon vesting of restricted stock units $ 11 (11)
Issuance of common stock upon vesting of restricted stock units, shares 10,503      
Net loss (4,637,066) (4,637,066)
Balance at Dec. 31, 2019 $ 13,737 17,249,868 (21,875,937) (4,612,332)
Balance, shares at Dec. 31, 2019 13,735,874      
Conversion of convertible notes into common stock $ 61 239,461 239,522
Conversion of convertible notes into common stock, shares 60,847      
Stock-based compensation 88,806 88,806
Exercise of stock options $ 42 1,446 1,488
Exercise of stock options, shares 42,525      
Issuance of common stock for consulting services $ 61 153,520 153,581
Issuance of common stock for consulting services, shares 61,000      
Issuance of common stock upon vesting of restricted stock units $ 122 289,272 289,394
Issuance of common stock upon vesting of restricted stock units, shares 122,177      
Net loss (1,345,642) (1,345,642)
Balance at Mar. 31, 2020 $ 14,023 18,022,373 (23,221,579) (5,185,183)
Balance, shares at Mar. 31, 2020 14,022,423      
Conversion of convertible notes into common stock $ 4,026 7,845,405 7,849,431
Conversion of convertible notes into common stock, shares 4,025,701      
Issuance of broker warrants in connection with convertible notes offering 277,037 277,037
Issuance costs in connection with conversion of convertible notes into common stock (161,881) (161,881)
Stock-based compensation 103,998 103,998
Exercise of stock options $ 34 1,157 1,191
Exercise of stock options, shares 34,020      
Issuance of common stock for consulting services $ 142 241,008 241,150
Issuance of common stock for consulting services, shares 142,083      
Issuance of common stock upon vesting of restricted stock units $ 15 38,520 38,535
Issuance of common stock upon vesting of restricted stock units, shares 15,370      
Net loss (7,091,060) (7,091,060)
Balance at Jun. 30, 2020 $ 18,240 $ 26,367,617 $ (30,312,639) $ (3,926,782)
Balance, shares at Jun. 30, 2020 18,239,597